AtaiBeckley (ATAI) Assets (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly Assets of $264.9 million for Q1 2026, down 9.51% quarter-over-quarter from $292.7 million in Q4 2025.

AtaiBeckley (ATAI) Assets (2020 - 2026) Analysis & Trends

AtaiBeckley's Assets history runs 3 years deep, the most recent figure standing at $264.9 million for Q1 2026.

In Q1 2026, Assets changed N/A year-over-year to $264.9 million; the TTM figure through Mar 2026 stood at $264.9 million (changed N/A YoY), while the FY2025 annual figure was $292.7 million, up 83.66% from the prior year.
Assets for Q1 2026 stood at $264.9 million, down from $292.7 million in the prior quarter.
Over five years, Assets peaked at $342.6 million in Q3 2022 and troughed at $885000.0 in Q1 2021.
A 5-year average of $178.6 million and a median of $239.8 million in 2025 frame the typical range for Assets.
Peak annual rise in Assets reached 83.66% in 2025, while the deepest fall reached 83.66% in 2025.
AtaiBeckley's Assets stood at $159.4 million in 2024, then soared by 83.66% to $292.7 million in 2025, then decreased by 9.51% to $264.9 million in 2026.
Business Quant data shows ATAI's Assets at $264.9 million in Q1 2026, $292.7 million in Q4 2025, and $159.4 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	27.42 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	41.73 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.03 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	4.32 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	9.18 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	15.59 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	19.82 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	5.56 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	2.10 Bn
10	AtaiBeckley	2.69 Bn	2.69 Bn	-	239.82 Mn

Download Data